AP
CRL icon

AHL Partners’s Charles River Laboratories CRL Stock Holding History

AHL Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$3M Sell
27,422
-22,449
-45% -$2.44M 0.05% 612
2017
Q3 		$5.39M Buy
49,871
+28,061
+129% +$2.88M 0.1% 377
2017
Q2 		$2.21M Buy
21,810
+14,767
+210% +$1.36M 0.05% 593
2017
Q1 		$633K Buy
7,043
+2,771
+65% +$235K 0.01% 919
2016
Q4 		$326K Sell
4,272
-1,988
-32% -$151K 0.01% 948
2016
Q3 		$522K Sell
6,260
-1,047
-14% -$87.8K 0.02% 825
2016
Q2 		$602K Buy
7,307
+3,785
+107% +$312K 0.03% 568
2016
Q1 		$268K Sell
3,522
-28,006
-89% -$2.07M 0.02% 684
2015
Q4 		$2.54M Buy
31,528
+26,040
+474% +$1.88M 0.2% 194
2015
Q3 		$349K Sell
5,488
-65,664
-92% -$4.72M 0.06% 514
2015
Q2 		$5M Buy
71,152
+3,636
+5% +$269K 0.2% 177
2015
Q1 		$5.35M Buy
67,516
+25,209
+60% +$1.86M 0.21% 146
2014
Q4 		$2.69M Buy
42,307
+38,079
+901% +$2.39M 0.14% 296
2014
Q3 		$253K Buy
+4,228
New +$242K 0.02% 639

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AHL Partners's CRL Position: Q4 2017 in Review

AHL Partners reduced its Charles River Laboratories (CRL) stake by 45% in Q4 2017, selling an estimated $2.44M and leaving 27,422 shares worth $3M. The position accounts for 0.05% of the portfolio, ranked #612.

AHL Partners first reported a position in CRL in Q3 2014 and has held it in 14 quarters since. The position peaked at $5.39M in Q3 2017. 339 funds tracked by Wall St. Rank hold CRL as of Q4 2017.

  • AHL Partners held 27,422 shares of Charles River Laboratories worth $3M as of Q4 2017.
  • AHL Partners sold 22,449 Charles River Laboratories shares in Q4 2017, an estimated $2.44M.
  • Charles River Laboratories made up 0.05% of AHL Partners's portfolio in Q4 2017, its #612 holding.
  • AHL Partners first reported a position in Charles River Laboratories in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Charles River Laboratories position peaked at $5.39M in Q3 2017.
  • 339 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.